IDARUBICIN, HIGH-DOSE CYTARABINE AND ETOPOSIDE FOR REMISSION INDUCTION IN THERAPY-RELATED ACUTE MYELOID-LEUKEMIA

被引：7

作者：

PHILPOTT, N

MEHTA, J

TRELEAVEN, J

POWLES, R

机构：

[1] Department of Haematology, Leukaemia Unit

[2] The Royal Marsden Hospital, Sutton, Surrey

来源：

LEUKEMIA & LYMPHOMA | 1994年 / 15卷 / 1-2期

关键词：

CYTARABINE; ETOPOSIDE; IDARUBICIN; SECONDARY ACUTE MYELOID LEUKEMIA; THERAPY-RELATED ACUTE MYELOID LEUKEMIA;

D O I：

10.3109/10428199409051686

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Five patients with therapy-related acute myeloid leukemia received combination induction chemotherapy with idarubicin, high-dose cytarabine, and etoposide. Complete remission was achieved in all patients with a single course of therapy. Treatment-related toxicity included nausea, vomiting, mucositis, diarrhea, and liver and kidney function abnormalities, and was low in all patients. There were no deaths during induction therapy. We conclude that this combination is well-tolerated in induction of remission in secondary acute myeloid leukemia, and warrants further assessment because of a very good complete remission rate.

引用

页码：127 / 130

页数：4

共 50 条

[41] Sense and nonsense of high-dose cytarabine for acute myeloid leukemia
Lowenberg, Bob
BLOOD, 2013, 121 (01) : 26 - 28
[42] High-dose cytarabine, etoposide and cisplatin salvage chemotherapy for relapsed adult acute myeloid leukemia.
Lee, JS
Lee, KW
Lee, WS
Kim, J
Yoon, SS
Park, S
Kim, BK
BLOOD, 2003, 102 (11) : 230B - 230B
[43] HIGH-DOSE CYTARABINE FOR INTENSIFICATION OF EARLY THERAPY OF CHILDHOOD ACUTE MYELOID-LEUKEMIA - A PEDIATRIC ONCOLOGY GROUP-STUDY
RAVINDRANATH, Y
STEUBER, CP
KRISCHER, J
CIVIN, CI
DUCORE, J
VEGA, R
PITEL, P
INOUE, S
BLEHER, E
SEXAUER, C
HUTTER, J
VIETTI, T
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) : 572 - 580
[44] A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia
Lee, Je-Hwan
Kim, Hawk
Joo, Young-Don
Lee, Won Sik
Bae, Sung Hwa
Zang, Dae Young
Kwon, Jihyun
Kim, Min Kyoung
Lee, Junglim
Lee, Gyeong Won
Lee, Jung-Hee
Choi, Yunsuk
Kim, Dae-Young
Lim, Sung-Nam
Lee, Sang-Min
Ryoo, Hun-Mo
Kim, Hyo Jung
Hyun, Myung Soo
Lee, Kyoo-Hyung
BLOOD, 2015, 126 (23)
[45] Idarubicin, cytarabine in standard or high-dose, and etoposide +/- lenograstim (G-CSF) for adult acute myeloid leukaemia (AML). Combinations giving high remission rates.
Lowenthal, RM
Bradstock, KM
Matthews, JP
Enno, A
Gill, D
Page, FJ
Rooney, KF
Taylor, KM
BLOOD, 1995, 86 (10) : 3059 - 3059
[46] LOW-DOSE CYTARABINE IN ACUTE MYELOID-LEUKEMIA
MANOHARAN, A
LEYDEN, MJ
SULLIVAN, J
MEDICAL JOURNAL OF AUSTRALIA, 1984, 141 (10) : 643 - 646
[47] ORAL IDARUBICIN AND LOW-DOSE CYTARABINE AS THE INITIAL TREATMENT OF ACUTE MYELOID-LEUKEMIA IN ELDERLY PATIENTS
HAROUSSEAU, JL
HUGUET, F
REIFFERS, J
COLLOMBAT, P
KOHSER, P
LEPRISE, PY
SOUTEYRAND, P
HURTELOUP, P
LEUKEMIA & LYMPHOMA, 1991, 5 (2-3) : 145 - 149
[48] ACUTE MYELOID-LEUKEMIA IN MANITOBA - THE CONSEQUENCES OF STANDARD 7+3 REMISSION-INDUCTION THERAPY FOLLOWED BY HIGH-DOSE CYTARABINE POSTREMISSION CONSOLIDATION FOR MYELOSUPPRESSION, INFECTIOUS MORBIDITY, AND OUTCOME
BOW, EJ
KILPATRICK, MG
SCOTT, BA
CLINCH, JJ
CHEANG, MS
CANCER, 1994, 74 (01) : 52 - 60
[49] INTENSIVE REMISSION INDUCTION AND CONSOLIDATION THERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
FERRANT, A
DOYEN, C
BOSLY, A
DELANNOY, A
CORNU, G
MICHAUX, JL
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 67 (03) : 375 - 375
[50] MULTICENTER STUDY ON INTENSIFIED REMISSION INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA
BUCHNER, T
URBANITZ, D
EMMERICH, B
FISCHER, JT
FULLE, HH
HEINECKE, A
HOSSFELD, DK
KOEPPEN, KM
LABEDZKI, L
LOFFLER, H
NOWROUSIAN, MR
PFREUNDSCHUH, M
PRALLE, H
RUHL, H
WENDT, FC
LEUKEMIA RESEARCH, 1982, 6 (06) : 827 - 831

← 1 2 3 4 5 →